HK Stock MarketDetailed Quotes

02186 LUYE PHARMA

Watchlist
  • 2.830
  • +0.010+0.35%
Trading Nov 8 13:31 CST
10.65BMarket Cap12.63P/E (TTM)

LUYE PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
5.87%3.07B
2.70%6.14B
1.87%2.9B
15.03%5.98B
-3.42%2.85B
-6.13%5.2B
-0.36%2.95B
-12.87%5.54B
-5.40%2.96B
22.90%6.36B
Operating income
5.87%3.07B
2.70%6.14B
1.87%2.9B
15.03%5.98B
-3.42%2.85B
-6.13%5.2B
-0.36%2.95B
-12.87%5.54B
-5.40%2.96B
22.90%6.36B
Cost of sales
-3.67%-996.03M
-5.31%-1.94B
-19.98%-960.75M
-2.09%-1.84B
19.76%-800.74M
-16.43%-1.8B
-30.57%-997.98M
-4.76%-1.55B
-9.35%-764.34M
-31.56%-1.48B
Operating expenses
-3.67%-996.03M
-5.31%-1.94B
-19.98%-960.75M
-2.09%-1.84B
19.76%-800.74M
-16.43%-1.8B
-30.57%-997.98M
-4.76%-1.55B
-9.35%-764.34M
-31.56%-1.48B
Gross profit
6.96%2.08B
1.54%4.2B
-5.21%1.94B
21.90%4.14B
4.93%2.05B
-14.88%3.4B
-11.11%1.95B
-18.21%3.99B
-9.63%2.2B
20.49%4.88B
Selling expenses
23.71%-850.83M
-13.00%-2.06B
-33.06%-1.12B
-6.74%-1.82B
-8.75%-838.15M
-2.46%-1.7B
11.80%-770.73M
18.23%-1.66B
13.37%-873.86M
-20.69%-2.03B
Administrative expenses
2.75%-289.18M
-10.48%-643.97M
-11.71%-297.34M
-2.11%-582.87M
5.57%-266.18M
-9.47%-570.84M
-13.65%-281.87M
1.47%-521.48M
4.12%-248.02M
-19.92%-529.28M
Operating interest expense
----
----
----
----
-9.25%-214.11M
5.79%-399.46M
---195.98M
-43.50%-424M
----
---295.46M
Special items of operating profit
-2,820.00%-131.08M
78.35%-129.28M
101.35%4.82M
25.05%-597.27M
-64.42%-356.83M
-80.79%-796.92M
-28.07%-217.02M
-13.93%-440.79M
6.39%-169.45M
-38.70%-386.89M
Operating profit
50.76%807.47M
20.52%1.37B
42.90%535.59M
1,615.70%1.14B
-23.21%374.81M
-108.00%-75.26M
-46.16%488.08M
-42.40%940.45M
-7.85%906.53M
-0.64%1.63B
Financing cost
9.45%-277.84M
-43.18%-675.45M
---306.84M
---471.76M
----
----
----
----
-84.84%-222.98M
----
Share of profits of associates
48.71%345K
-4.45%794K
-59.15%232K
18.54%831K
58.66%568K
-59.39%701K
-65.11%358K
42.17%1.73M
211.85%1.03M
35.34%1.21M
Earning before tax
131.44%529.98M
4.53%700.1M
-39.00%228.99M
998.32%669.76M
-23.15%375.37M
-107.91%-74.56M
-28.65%488.44M
-42.34%942.17M
-20.71%684.58M
10.89%1.63B
Tax
-9.76%-91.8M
-86.23%-161.02M
-15.86%-83.63M
-23.13%-86.47M
10.27%-72.19M
70.61%-70.23M
44.23%-80.45M
14.62%-238.91M
14.17%-144.25M
-67.09%-279.83M
After-tax profit from continuing operations
201.46%438.18M
-7.58%539.08M
-52.06%145.35M
502.88%583.3M
-25.69%303.19M
-120.59%-144.78M
-24.49%407.99M
-48.06%703.27M
-22.29%540.33M
3.68%1.35B
Earning after tax
201.46%438.18M
-7.58%539.08M
-52.06%145.35M
502.88%583.3M
-25.69%303.19M
-120.59%-144.78M
-24.49%407.99M
-48.06%703.27M
-22.29%540.33M
3.68%1.35B
Minority profit
1,188.95%50.34M
130.09%6.47M
-174.70%-4.62M
-107.02%-21.51M
-71.09%6.19M
-212.89%-10.39M
2,247.04%21.41M
92.11%-3.32M
102.54%912K
-1,704.77%-42.08M
Profit attributable to shareholders
158.60%387.84M
-11.94%532.61M
-49.50%149.98M
550.03%604.81M
-23.17%297M
-119.02%-134.39M
-28.33%386.59M
-49.39%706.59M
-26.23%539.42M
7.12%1.4B
Basic earnings per share
153.94%0.1031
-17.78%0.1429
-52.46%0.0406
545.64%0.1738
-24.56%0.0854
-117.59%-0.039
-33.02%0.1132
-49.13%0.2217
-25.97%0.169
7.29%0.4358
Diluted earnings per share
153.94%0.1031
-17.78%0.1429
-52.46%0.0406
545.64%0.1738
-24.36%0.0854
-117.63%-0.039
-33.04%0.1129
-48.96%0.2212
-25.79%0.1686
7.14%0.4334
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 5.87%3.07B2.70%6.14B1.87%2.9B15.03%5.98B-3.42%2.85B-6.13%5.2B-0.36%2.95B-12.87%5.54B-5.40%2.96B22.90%6.36B
Operating income 5.87%3.07B2.70%6.14B1.87%2.9B15.03%5.98B-3.42%2.85B-6.13%5.2B-0.36%2.95B-12.87%5.54B-5.40%2.96B22.90%6.36B
Cost of sales -3.67%-996.03M-5.31%-1.94B-19.98%-960.75M-2.09%-1.84B19.76%-800.74M-16.43%-1.8B-30.57%-997.98M-4.76%-1.55B-9.35%-764.34M-31.56%-1.48B
Operating expenses -3.67%-996.03M-5.31%-1.94B-19.98%-960.75M-2.09%-1.84B19.76%-800.74M-16.43%-1.8B-30.57%-997.98M-4.76%-1.55B-9.35%-764.34M-31.56%-1.48B
Gross profit 6.96%2.08B1.54%4.2B-5.21%1.94B21.90%4.14B4.93%2.05B-14.88%3.4B-11.11%1.95B-18.21%3.99B-9.63%2.2B20.49%4.88B
Selling expenses 23.71%-850.83M-13.00%-2.06B-33.06%-1.12B-6.74%-1.82B-8.75%-838.15M-2.46%-1.7B11.80%-770.73M18.23%-1.66B13.37%-873.86M-20.69%-2.03B
Administrative expenses 2.75%-289.18M-10.48%-643.97M-11.71%-297.34M-2.11%-582.87M5.57%-266.18M-9.47%-570.84M-13.65%-281.87M1.47%-521.48M4.12%-248.02M-19.92%-529.28M
Operating interest expense -----------------9.25%-214.11M5.79%-399.46M---195.98M-43.50%-424M-------295.46M
Special items of operating profit -2,820.00%-131.08M78.35%-129.28M101.35%4.82M25.05%-597.27M-64.42%-356.83M-80.79%-796.92M-28.07%-217.02M-13.93%-440.79M6.39%-169.45M-38.70%-386.89M
Operating profit 50.76%807.47M20.52%1.37B42.90%535.59M1,615.70%1.14B-23.21%374.81M-108.00%-75.26M-46.16%488.08M-42.40%940.45M-7.85%906.53M-0.64%1.63B
Financing cost 9.45%-277.84M-43.18%-675.45M---306.84M---471.76M-----------------84.84%-222.98M----
Share of profits of associates 48.71%345K-4.45%794K-59.15%232K18.54%831K58.66%568K-59.39%701K-65.11%358K42.17%1.73M211.85%1.03M35.34%1.21M
Earning before tax 131.44%529.98M4.53%700.1M-39.00%228.99M998.32%669.76M-23.15%375.37M-107.91%-74.56M-28.65%488.44M-42.34%942.17M-20.71%684.58M10.89%1.63B
Tax -9.76%-91.8M-86.23%-161.02M-15.86%-83.63M-23.13%-86.47M10.27%-72.19M70.61%-70.23M44.23%-80.45M14.62%-238.91M14.17%-144.25M-67.09%-279.83M
After-tax profit from continuing operations 201.46%438.18M-7.58%539.08M-52.06%145.35M502.88%583.3M-25.69%303.19M-120.59%-144.78M-24.49%407.99M-48.06%703.27M-22.29%540.33M3.68%1.35B
Earning after tax 201.46%438.18M-7.58%539.08M-52.06%145.35M502.88%583.3M-25.69%303.19M-120.59%-144.78M-24.49%407.99M-48.06%703.27M-22.29%540.33M3.68%1.35B
Minority profit 1,188.95%50.34M130.09%6.47M-174.70%-4.62M-107.02%-21.51M-71.09%6.19M-212.89%-10.39M2,247.04%21.41M92.11%-3.32M102.54%912K-1,704.77%-42.08M
Profit attributable to shareholders 158.60%387.84M-11.94%532.61M-49.50%149.98M550.03%604.81M-23.17%297M-119.02%-134.39M-28.33%386.59M-49.39%706.59M-26.23%539.42M7.12%1.4B
Basic earnings per share 153.94%0.1031-17.78%0.1429-52.46%0.0406545.64%0.1738-24.56%0.0854-117.59%-0.039-33.02%0.1132-49.13%0.2217-25.97%0.1697.29%0.4358
Diluted earnings per share 153.94%0.1031-17.78%0.1429-52.46%0.0406545.64%0.1738-24.36%0.0854-117.63%-0.039-33.04%0.1129-48.96%0.2212-25.79%0.16867.14%0.4334
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data